Skip to main content

Table 3 Characteristics of patients present at the ADDO

From: Expanding access to parasite-based malaria diagnosis through retail drug shops in Tanzania: evidence from a randomized trial and implications for treatment

 

Pre-intervention

Post-intervention

Subsidized (n = 54)

Unsubsidized (n = 46)

Control (n = 59)

χ 2 p value

Subsidized (n = 217)

Unsubsidized (n = 247)

Control (n = 244)

χ 2 p value

Patient age (median, range)

24.5 (1–66)

22 (<1–62)

27 (<1–83)

 

23 (<1–79)

22 (1–92)

24 (1–74)

 

Male (%, 95% CI)

48.1 (34.6–61.7)

47.8 (33.1–62.5)

50.8 (37.8–63.8)

0.941

47.9 (41.2–54.6)

53.0 (46.8–59.3)

50.8 (44.5–57.1)

0.546

Days Ill (median, range)

3 (<1, 14)

3 (<1, 30)

3 (<1, 14)

 

2 (<1, 60)

3 (<1, 30)

2 (<1, 60)

 

ADDO first place treatment sought (%, 95% CI)

70.4 (58.0–82.8)

65.2 (51.2–79.2)

80.0 (69.2–90.1)

0.240

77.4 (71.8–83.0)

74.8 (69.4–80.2)

75.4 (70.0–80.8)

0.792

Malaria test prior to ADDO Visit (%, 95% CI)

16.7 (6.6–26.8)

21.7 (9.6–33.9)

3.4 (0.0–8.1)

0.015

11.1 (6.8–15.4)

13.4 (9.0–17.8)

14.9 (10.2–19.7)

0.502